(Q47941386)

6 February 2018

title

A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide (English)

1 reference

6 February 2018

0 references

0 references

H Döbeli

1

1 reference

6 February 2018

N Draeger

2

1 reference

6 February 2018

G Huber

3

1 reference

6 February 2018

P Jakob

4

1 reference

6 February 2018

D Schmidt

5

1 reference

6 February 2018

B Seilheimer

6

1 reference

6 February 2018

D Stüber

7

1 reference

6 February 2018

B Wipf

8

1 reference

6 February 2018

M Zulauf

9

1 reference

6 February 2018

publication date

1 September 1995

1 reference

6 February 2018

published in

Bio/technology

1 reference

6 February 2018

volume

13

1 reference

6 February 2018

issue

9

1 reference

6 February 2018

page(s)

988-993

1 reference

6 February 2018

The molecular pathology of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

7 January 2021

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

7 January 2021

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

7 January 2021

New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

7 January 2021

NMR identification of the formic acid-modified residue in Alzheimer's amyloid protein

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

7 January 2021

Estimation of globular protein secondary structure from circular dichroism.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0995-988

7 January 2021

Identifiers

DOI

10.1038/NBT0995-988

1 reference

6 February 2018

1 reference

6 February 2018